Overview
AQST market data
Price History
AQST price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for AQST. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Aquestive Therapeutics Files Prospectus For Offering 230,271 Common Shares On Behalf Of Selling ShareholdersBenzinga · Jun 26, 2026, 8:30 PM
Staar Surgical Posts Upbeat Q1 Results, Joins Cisco, Yeti Holdings And Other Big Stocks Moving Higher On ThursdayBenzinga · May 14, 2026, 2:01 PM
Aquestive Therapeutics Q1 2026 Earnings Call: Complete TranscriptBenzinga · May 14, 2026, 1:09 PM
Aquestive Therapeutics shares are trading higher after the company reported better-than-expected Q1 financial results.Benzinga · May 14, 2026, 11:57 AM
Aquestive Therapeutics Affirms FY2026 Sales Guidance of $46.000M-$50.000M vs $48.072M EstBenzinga · May 13, 2026, 8:02 PM
Aquestive Therapeutics Q1 EPS $(0.07) Beats $(0.15) Estimate, Sales $14.446M Beat $10.896M EstimateBenzinga · May 13, 2026, 8:02 PM
Earnings Scheduled For May 13, 2026Benzinga · May 13, 2026, 11:11 AM